Evidence map›Paper›PMID 30046842›Full record

ArticleRheumatology international2018

Correction to: The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern.

Luis Cea-Calvo, Enrique Raya, Carlos Marras, Tarek C Salman-Monte, Ana Ortiz, Georgina Salvador, Indalecio Monteagudo, Loreto Carmona, Sabela Fernandez, Maria J Arteaga and 1 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Luis Cea-CalvoMedical Affairs Department, Merck Sharp & Dohme S.A., Calle de Josefa Valcárcel 38, 28027, Madrid, Spain. luis.cea@merck.com.
Enrique RayaHospital Universitario San Cecilio, Granada, Spain.
Carlos MarrasHospital Universitario Virgen de Arrixaca, Murcia, Spain.
Tarek C Salman-MonteHospital del Mar, Barcelona, Spain.
Ana OrtizHospital La Princesa, IIS La Princesa, Madrid, Spain.
Georgina SalvadorHospital Universitario Mutua de Terrassa, Barcelona, Spain.
Indalecio MonteagudoHospital Universitario Gregorio Marañón, Madrid, Spain.
Loreto CarmonaInstituto de Salud Musculoesquelética (InMusc), Madrid, Spain.
Sabela FernandezMedical Affairs Department, Merck Sharp & Dohme S.A., Calle de Josefa Valcárcel 38, 28027, Madrid, Spain.
Maria J ArteagaMedical Affairs Department, Merck Sharp & Dohme S.A., Calle de Josefa Valcárcel 38, 28027, Madrid, Spain.
Jaime Calvo-AlénHospital Txagorritxu, Araba, Vitoria, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication, the family name of the last author was incorrect. The correct name should read as Jaime Calvo-Alén.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.